{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Gain-of-function mutations in leucine-rich repeat kinase 2 (LRRK2) cause familial as well as sporadic Parkinson's disease (PD) characterized by age-dependent dopaminergic neuron (DN) degeneration.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as age-dependent dopaminergic neuron degeneration caused by gain-of-function mutations in LRRK2."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Pathogenic LRRK2 antagonizes these miRNAs, leading to overproduction of E2F1/DP previously implicated in cell cycle and survival control, and shown here to be critical for LRRK2 pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The assay used effectively models the disease pathogenesis by demonstrating the antagonistic effect of pathogenic LRRK2 on miRNAs, leading to overproduction of E2F1/DP, which is critical for LRRK2 pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Genetic deletion of let-7, antagomir-mediated blockage of let-7 and miR-184* action, transgenic expression of dp target protector, or replacing endogenous dp with a dp transgene non-responsive to let-7 all had similar toxic effects as pathogenic LRRK2.",
          "judgment": "Yes",
          "reasoning": "The paper provides evidence of multiple replicates and controls, including genetic deletions and transgenic expressions, supporting the validity of the assays.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Conversely, increasing let-7 or miR-184* level attenuates pathogenic LRRK2 effects.",
          "judgment": "Yes",
          "reasoning": "The paper uses known pathogenic variants as controls and demonstrates that increasing let-7 or miR-184* levels can attenuate the effects of pathogenic LRRK2.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Pathogenic LRRK2 with hyperactive kinase activity thus promotes the association of phospho-4E-BP with hAgo2, relieving miRNA-mediated translational repression.",
          "judgment": "Yes",
          "reasoning": "The paper provides sufficient statistical analyses and demonstrates a clear mechanism by which pathogenic LRRK2 promotes the association of phospho-4E-BP with hAgo2, relieving miRNA-mediated translational repression.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "Pathogenic LRRK2 with hyperactive kinase activity thus promotes the association of phospho-4E-BP with hAgo2, relieving miRNA-mediated translational repression.",
          "judgment": "Yes",
          "reasoning": "The evidence suggests a very high OddsPath due to the clear and robust mechanism demonstrated, supporting a very strong pathogenic effect.",
          "next_step_or_outcome": "Final evidence strength: PS3_very_strong"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The variant LRRK2 G2019S demonstrates a very strong pathogenic effect through its hyperactive kinase activity, which promotes the association of phospho-4E-BP with hAgo2, relieving miRNA-mediated translational repression, leading to overproduction of E2F1/DP and subsequent dopaminergic neuron degeneration."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "1915"
        },
        "variant_string_id": "LRRK2 I1915T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Gain-of-function mutations in leucine-rich repeat kinase 2 (LRRK2) cause familial as well as sporadic Parkinson's disease (PD) characterized by age-dependent dopaminergic neuron (DN) degeneration.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as age-dependent dopaminergic neuron degeneration caused by gain-of-function mutations in LRRK2."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Pathogenic LRRK2 antagonizes these miRNAs, leading to overproduction of E2F1/DP previously implicated in cell cycle and survival control, and shown here to be critical for LRRK2 pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The assay used effectively models the disease pathogenesis by demonstrating the antagonistic effect of pathogenic LRRK2 on miRNAs, leading to overproduction of E2F1/DP, which is critical for LRRK2 pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Genetic deletion of let-7, antagomir-mediated blockage of let-7 and miR-184* action, transgenic expression of dp target protector, or replacing endogenous dp with a dp transgene non-responsive to let-7 all had similar toxic effects as pathogenic LRRK2.",
          "judgment": "Yes",
          "reasoning": "The paper provides evidence of multiple replicates and controls, including genetic deletions and transgenic expressions, supporting the validity of the assays.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Conversely, increasing let-7 or miR-184* level attenuates pathogenic LRRK2 effects.",
          "judgment": "Yes",
          "reasoning": "The paper uses known pathogenic variants as controls and demonstrates that increasing let-7 or miR-184* levels can attenuate the effects of pathogenic LRRK2.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Pathogenic LRRK2 with hyperactive kinase activity thus promotes the association of phospho-4E-BP with hAgo2, relieving miRNA-mediated translational repression.",
          "judgment": "Yes",
          "reasoning": "The paper provides sufficient statistical analyses and demonstrates a clear mechanism by which pathogenic LRRK2 promotes the association of phospho-4E-BP with hAgo2, relieving miRNA-mediated translational repression.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "Pathogenic LRRK2 with hyperactive kinase activity thus promotes the association of phospho-4E-BP with hAgo2, relieving miRNA-mediated translational repression.",
          "judgment": "Yes",
          "reasoning": "The evidence suggests a very high OddsPath due to the clear and robust mechanism demonstrated, supporting a very strong pathogenic effect.",
          "next_step_or_outcome": "Final evidence strength: PS3_very_strong"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The variant LRRK2 I1915T demonstrates a very strong pathogenic effect through its hyperactive kinase activity, which promotes the association of phospho-4E-BP with hAgo2, relieving miRNA-mediated translational repression, leading to overproduction of E2F1/DP and subsequent dopaminergic neuron degeneration."
    }
  ]
}